BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34527159)

  • 1. Maintaining care delivery for non-communicable diseases in the face of the COVID-19 pandemic in western Kenya.
    Kamano J; Naanyu V; Ayah R; Limo O; Gathecha G; Saenyi E; Jefwa P; Too K; Manji I; Gala P; Vedanthan R
    Pan Afr Med J; 2021; 39():143. PubMed ID: 34527159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring key-stakeholder perceptions on non-communicable disease care during the COVID-19 pandemic in Kenya.
    Sureshkumar S; Mwangi KJ; Gathecha G; Marcus K; Kohlbrenner B; Issom D; Benissa MR; Aebischer-Perone S; Braha N; Candela E; Chhabra KG; Desikachari BR; Dondi A; Etchebehere M; Kengne AP; Missoni E; Mustapha F; Palafox B; Pati S; Madhu PP; Peer N; Quint J; Tabrizi R; Yusoff H; Oris M; Beran DH; Balabanova D; Etter JF
    Pan Afr Med J; 2023; 44():153. PubMed ID: 37455892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human-centered design as a guide to intervention planning for non-communicable diseases: the BIGPIC study from Western Kenya.
    Leung CL; Naert M; Andama B; Dong R; Edelman D; Horowitz C; Kiptoo P; Manyara S; Matelong W; Matini E; Naanyu V; Nyariki S; Pastakia S; Valente T; Fuster V; Bloomfield GS; Kamano J; Vedanthan R
    BMC Health Serv Res; 2020 May; 20(1):415. PubMed ID: 32398131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policies for type 2 diabetes and non-communicable disease management during the COVID-19 pandemic in Kenya and Tanzania: a desk review and views of decision-makers.
    Mohamed SF; Kisia L; Mashiashi I; Mair F; Wisdom JP; Bunn C; Gray C; Kibe PM; Sanya RE; Karugu CH; Mtenga SM; Binyaruka P; Asiki G
    BMJ Open; 2024 Mar; 14(3):e073261. PubMed ID: 38531573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health system adaptions to improve care for people living with non-communicable diseases during COVID-19 in low-middle income countries: A scoping review.
    Baatiema L; Sanuade OA; Allen LN; Abimbola S; Hategeka C; Koram KA; Kruk ME
    J Glob Health; 2023 Mar; 13():06006. PubMed ID: 36862142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in policy reforms for non-communicable diseases: the case of diabetes in Kenya.
    Shiroya V; Neuhann F; Müller O; Deckert A
    Glob Health Action; 2019; 12(1):1611243. PubMed ID: 31117896
    [No Abstract]   [Full Text] [Related]  

  • 7. Innovations to Sustain Non-Communicable Disease Services in the Context of COVID-19: Report from Pakkred District, Nonthaburi Province, Thailand.
    Songsermpong S; Bunluesin S; Khomgongsuwan P; Junthon S; Cazabon D; Moran AE; Garg R
    Glob Heart; 2021 Jun; 16(1):44. PubMed ID: 34211830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: implications for NCDs and the continuity of care in Sub-Saharan Africa.
    Owopetu O; Fasehun LK; Abakporo U
    Glob Health Promot; 2021 Jun; 28(2):83-86. PubMed ID: 33579179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Readiness of health facilities to deliver non-communicable diseases services in Kenya: a national cross-sectional survey.
    Ammoun R; Wami WM; Otieno P; Schultsz C; Kyobutungi C; Asiki G
    BMC Health Serv Res; 2022 Aug; 22(1):985. PubMed ID: 35918710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid assessment of the impact of coronavirus disease (COVID- 19) pandemic on health care & service delivery for noncommunicable diseases in India.
    Nath A; Sudarshan KL; Rajput GK; Mathew S; Chandrika KRR; Mathur P
    Diabetes Metab Syndr; 2022 Oct; 16(10):102607. PubMed ID: 36115089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of COVID-19 on the care of people living with noncommunicable diseases in low- and middle-income countries: an online survey of physicians and pharmacists in nine countries.
    Bullen C; McCormack J; Calder A; Parag V; Subramaniam K; Majumdar A; Huang PH; Devi R; El Bizri L; Goodyear-Smith F
    Prim Health Care Res Dev; 2021 Jun; 22():e30. PubMed ID: 34120672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mixed-method study on the provision of remote consultations for non-communicable disease patients during the first wave of the COVID-19 pandemic in Latvia: lessons for the future.
    Kursīte M; Stars I; Strēle I; Gobiņa I; Ķīvīte-Urtāne A; Behmane D; Dūdele A; Villeruša A
    BMC Health Serv Res; 2022 Feb; 22(1):263. PubMed ID: 35219328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reframing Non-Communicable Diseases and Injuries for Equity in the Era of Universal Health Coverage: Findings and Recommendations from the Kenya NCDI Poverty Commission.
    Mwangi K; Gathecha G; Nyamongo M; Kimaiyo S; Kamano J; Bukachi F; Odhiambo F; Meme H; Abubakar H; Mwangi N; Nato J; Oti S; Kyobutungi C; Wamukoya M; Mohamed SF; Wanyonyi E; Ali Z; Nyanjau L; Nganga A; Kiptui D; Karagu A; Nyangasi M; Mwenda V; Mwangi M; Mulaki A; Mwai D; Waweru P; Anyona M; Masibo P; Beran D; Guessous I; Coates M; Bukhman G; Gupta N
    Ann Glob Health; 2021 Jan; 87(1):3. PubMed ID: 33505862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary care for the urban poor in India during the pandemic: Uninterrupted management of non-communicable diseases and home-based care of patients with COVID-19 infection.
    Abraham S; John SM; Gupta A; Biswas S; Khare MM; Mukherjee P; Frankline AC
    Front Public Health; 2022; 10():1043597. PubMed ID: 36699918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to Medicines for Non-Communicable Diseases (NCDS) during COVID-19 in Kenya: A Descriptive Commentary.
    Kiragu ZW; Gathecha G; Mwangi MK; Ndegwa Z; Pastakia S; Nyagah D; Cizungu RN; Takah Mutwiri M; Ndolo M; Wirtz VJ
    Health Syst Reform; 2021 Jan; 7(1):e1984865. PubMed ID: 34748436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supply-chain strategies for essential medicines in rural western Kenya during COVID-19.
    Tran DN; Were PM; Kangogo K; Amisi JA; Manji I; Pastakia SD; Vedanthan R
    Bull World Health Organ; 2021 May; 99(5):388-392. PubMed ID: 33958827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for the use of mathematical modelling to support decision-making on integration of non-communicable diseases into HIV care.
    Kibachio J; Mwenda V; Ombiro O; Kamano JH; Perez-Guzman PN; Mutai KK; Guessous I; Beran D; Kasaie P; Weir B; Beecroft B; Kilonzo N; Kupfer L; Smit M
    J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25505. PubMed ID: 32562338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Layering and scaling up chronic non-communicable disease care on existing HIV care systems and acute care settings in Kenya: a cost and budget impact analysis.
    Osetinsky B; Mwangi A; Pastakia S; Wilson-Barthes M; Kimetto J; Rono K; Laktabai J; Galárraga O
    J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25496. PubMed ID: 32562355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive primary health care and non-communicable diseases management: a case study of El Salvador.
    Jimenez Carrillo M; León García M; Vidal N; Bermúdez K; De Vos P
    Int J Equity Health; 2020 Apr; 19(1):50. PubMed ID: 32252764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to healthcare services for people with non-communicable diseases during the COVID-19 pandemic in Ibadan, Nigeria: a qualitative study.
    Ojewale LY; Mukumbang FC
    BMC Health Serv Res; 2023 Nov; 23(1):1231. PubMed ID: 37946244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.